JDD HighlightsJDD WebinarsThe Latest

New Innovation for Addressing Hyperpigmentation in Diverse Patients

By October 11, 2024No Comments

JDD Multimedia

New Innovation for Addressing Hyperpigmentation in Diverse Patients

Faculty


Andrew Alexis MD, MPH
Professor of Clinical Dermatology
Vice-Chair for Diversity and Inclusion
Weill Cornell Medicine


Heather Woolery-Lloyd, MD FAAD
Director, Skin of  Color Division
Dr Phillip Frost Department of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine

Hawasatu Dumbuya, Ph.D.
Director, Clinical Research & Medical Affairs
La Roche-Posay, L’Oreal USA

Watch On Demand

“Please sir, I want some more:” When Rescue Becomes Routine With Prednisone in IBD Care

| Featured Articles, Latest News, Podcast, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments
Guest: Dr. Adelina Hung For decades, corticosteroids have been the gastrointestinal equivalent of duct tape: they fix almost everything, at least long enough to convince us the job is done.…

The PASI Paradigm Shift: How Higher Clinical Trial Endpoints Are Reshaping Dermatology

| Dermatology Podcast Archives, Featured Articles, Latest News, Podcast, Podcast Highlights | No Comments
Remember when PASI 75 was the gold medal? Today, it barely makes the podium. In this episode of the JDD Podcast, host Dr. Adam Friedman welcomes Dr. James Song for…

(P)Steroids & the Psyche: The Problems Nobody Put on the Prescription Label

| Featured Articles, Latest News, Podcast, Podcast Highlights, The JDD Steroid Stewardship Podcast | No Comments
Guest: Dr. Lucinda Whitney When corticosteroid risks come up, most clinicians immediately think about osteoporosis, hyperglycemia, infection risk, or adrenal suppression. But what about the organ sitting between the ears?…

Leave a Reply